Torrent Pharma announced on 29 June 2025 that it is in definitive agreements with global investment giant KKR to acquire a majority stake in JB Chemicals. The deal is set to be carried out at an equity valuation of ₹25,689 crores on a fully diluted basis from KKR-owned Tau Investment Holdings.
